baber/WOPTO huggingface dataset:
Patent EP-4195082-A1 (EP)
IPC: G06F21/56
Filed: 2021-12-09
Abstract: A method of sanitising a document is provided. The method comprises: receiving at least one document having embedded document objects; identifying the document file format of the at least one document; using the document file format to convert the document to an XML format; in the XML document, finding reference to the document objects; redacting, deleting or ignoring the document objects; and converting the modified XML document into the original document file format to create a reformed document. A document sanitiser, a computer program and a non-transitory machinereadable storage medium are also provided.
Patent EP-4040385-A1 (EP)
Title: Procédé de détection automatique de dommages sur un véhicule automobile
Inventor: PERRET-MEYER ALEXANDRE
IPC: G06T7/00
Filed: 2021-02-05
Abstract: Procédé (1) mis en œuvre par ordinateur de détection de dommages sur un véhicule automobileCaractérisé en ce qu'il comprend :- Un sous-procédé de détection (12) des parties externes du véhicule automobile (100) sur ladite au moins une image de référence ;- Un sous-procédé de détection (13) de dommages comprenant, pour chaque image acquise à l'étape d'acquisition (10) :o Une étape d'association (132) au cours de laquelle on détermine une fonction de transformation de plan entre ladite image et ladite au moins une image de référence ;o Une étape de transposition (133) des dommages détectés dans ladite image sur ladite au moins une image de référence par ladite fonction de transformation de plan déterminée.
Patent EP-4079327-A1 (EP)
Inventor: SKERDI HAVIARI
IPC: A61K47/64
Filed: 2021-04-22
Abstract: The present invention relates to a drug conjugate of the following formula (I): BdL−Dn wherein,D is a drug moiety D is a drug moiety deriving from a cytotoxic drug selected from the group consisting of Ombrabulin (II), N-[[(2,2-Diacetoxyethyl)oxy]ethyl]doxorubicin (III), N-(2-chlorobenzyl)-10-methylaminocolchicine (IV), Mitomycin A (V), BMS-310705 (VI), and HTI-042 (VII), wherein the point of attachment with L is the nitrogen atom of the amino group or the oxygen atom of the hydroxyl group marked with **, and derivatives thereof;L is a cleavable linker comprising a self-immolative moiety (L<sub>SI</sub>) and an enzyme-cleavable unit (L<sub>C</sub>);Bd is a binder selected from the group consisting of the molecules that bind to a targeted antigen such as an antigen selected from the group consisting of proteins, glycoproteins, glycolipids, carbohydrates, or a combination thereof; andn is an integer comprised from 1 to 4;or a pharmaceutically acceptable salt thereof.
Patent EP-4093530-A1 (EP)
Inventor: SALOM RAFAEL
IPC: B01D36/00
Filed: 2021-01-20
Abstract: Es werden ein Filter (12) zur Filtrierung von Fluid, eine Bypass-Ventilanordnung (18) und eine Diffusoreinrichtung (20) für einen Filter (12) beschrieben. Die Bypass-Ventilanordnung (18) ist fluidströmungstechnisch zwischen einem Fluideinlass (54) und einem Fluidauslass (30) des Filters (12) so angeordnet ist, dass sie in ihrem Öffnungszustand den Fluideinlass (54) fluidströmungstechnisch mit dem Fluidauslass (30) verbindet. Die Bypass-Ventilanordnung (18) weist einen Ventil-Verschlusskörper, welcher zwischen wenigstens einer Schließstellung und wenigstens einer Öffnungsstellung bewegbar ist, und einen Ventilsitz, an den das wenigstens eine Ventil-Verschlusskörper in wenigstens einer Schließstellung dicht anliegen kann, auf. Die Bypass-Ventilanordnung (18) weist ein Ventilgehäuse, in dem der Ventil-Verschlusskörper bewegbar angeordnet ist, und ein Ventilsitzelement, welches wenigstens einen Ventilsitz aufweist, auf. Das Ventilsitzelement ist mittels wenigstens einer mechanischen Verbindung mit wenigstens einem Teil des wenigstens einen Ventilgehäuses verbunden. Die Verbindung ist mittels wenigstens einer Relativdrehung zwischen dem wenigstens einen Ventilsitzelement und dem wenigstens einen Teil des wenigstens einen Ventilgehäuses (120) um eine gedachte Ventilachse der wenigstens eine Bypass-Ventilanordnung realisierbar. Die Diffusoreinrichtung (20) weist einen Diffusor-Anschlussabschnitt auf, mit welchem die Diffusoreinrichtung (20) mit wenigstens einem Fluidauslass (30) eines Filtergehäuses (14) des Filters (12) fluidleitungstechnisch verbunden ist. Die Diffusoreinrichtung (20) weist mehrere Fluidleitflächen auf.
Patent EP-4264493-A1 (EP)
Inventor: PEREZ NIEVES NICOLAS
IPC: G06N3/00
Filed: 2021-02-04
Abstract: Described is a machine learning apparatus (800) comprising one or more processors (801) configured to form an output value function for achieving a predetermined objective by receiving (601) an initial environment state, an initial state of a first agent function and an initial state of a second agent function; and iteratively performing the steps of: (i) implementing (602) a current state of the first agent function in dependence on a current environmental state to form a subsequent environmental state and a first reward; (ii) a first determining step (603) comprising determining by means of the second agent function whether to use a second reward; (iii) if that determination has a negative outcome, refining (604) the first agent function in dependence on the first reward; and if that determination has a positive outcome, computing the second reward according to a predetermined reward function and refining the first agent function in dependence on the first reward and the second reward; (iv) refining (605) the second agent function in dependence on a performance of the first agent function in meeting the predetermined objective; and (v) adopting (606) the subsequent environmental state as the current environmental state; and subsequently: outputting (607) the current state of the first agent function as the output value function. This can allow for automated reward-shaping which requires no a priori human input.
Patent EP-4125780-A1 (EP)
Title: Improving the fastness to washing of pigment-containing dyes by using an oxidative pretreatment agent
Inventor: KRUCK CONSTANZE
IPC: A61K8/22
Filed: 2021-02-01
Abstract: The present invention relates to a method for dyeing keratin material, in particular human hair, comprising the following steps: applying a pretreatment agent (V) to the keratin material, the pretreatment agent containing at least one oxidation agent in a cosmetic carrier (V-1), and applying a dye (F) to the keratin material, the dye containing (F-1) at least one amino-functionalized silicone polymer and (F-2) at least one pigment.
Patent EP-4118130-A1 (EP)
Inventor: LANGER MARCEL
IPC: C08G18/48
Filed: 2021-03-04
Abstract: Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von Polyethercarbonatpolyolen durch Anlagerung von Alkylenoxid und Kohlendioxid an eine H-funktionelle Startersubstanz in Anwesenheit eines DMC-Katalysators oder eines Metallkomplexkatalysators auf Basis der Metalle Cobalt und/oder Zink, wobei (γ) Alkylenoxid und Kohlendioxid an eine H-funktionelle Startersubstanz in einem Reaktor in Anwesenheit eines DMC-Katalysators oder eines Metallkomplexkatalysators auf Basis der Metalle Cobalt und/oder Zink angelagert werden, dadurch gekennzeichnet, dass das Alkylenoxid einen Anteil von 5 bis 50 Gew.-% Ethylenoxid, bezogen auf das Gesamtgewicht des eingesetzten Alkylenoxids, enthält und die Anlagerung des Ethylenoxids unter Kohlendioxid-haltiger Atmosphäre durchgeführt wird.
Patent EP-4118876-A1 (EP)
Inventor: DA SILVA ICARO L J
IPC: H04W36/00
Filed: 2021-03-02
Abstract: Embodiments herein relate to e.g. a method performed by a user equipment, UE, (10) for handling cell change of a secondary cell for the UE (10). The UE receives from a master node (12), a message of a first RAT comprising a reconfiguration message for a conditional reconfiguration of the secondary cell of a second RAT. The UE transmits to 5the master node, a first complete message of the second RAT embedded in another message of the first RAT, wherein the first complete message indicates that the UE is able to comply to the conditional reconfiguration. The UE (10) further transmits to the master node (12), upon fulfilment of a condition of the conditional reconfiguration, a second complete message of the second RAT embedded in a RRC message of the first 10RAT.(FIG. 5)
Patent EP-4139743-A1 (EP)
Inventor: CUSTERS KRISTOF
IPC: G03F1/64
Filed: 2021-03-25
Abstract: Un cadre de pellicule (17) comprend : une première partie (40) ; et une pluralité de secondes parties (42). La première partie est destinée à être reliée à une bordure (19a) d'une pellicule (19). La première partie comprend un corps creux et généralement rectangulaire. La pluralité de secondes parties sont destinées à être reliées à un dispositif de formation de motifs (MA). La première partie et la pluralité de secondes parties sont toutes formées à partir d'un premier matériau. Chacune des secondes parties est reliée à la première partie par une partie ressort (44) formée à partir du premier matériau. Un tel cadre de pellicule est avantageux puisque la première partie, la pluralité de secondes parties et les parties ressort sont toutes formées à partir du même matériau. Ceci simplifie considérablement la fabrication du cadre de pellicule. Par exemple, toutes les parties du cadre de pellicule peuvent être formées ensemble d'un seul tenant.
Patent EP-4132702-A1 (EP)
Inventor: RIESTER MARKUS
IPC: B01L3/00
Filed: 2021-04-07
Abstract: The invention relates to a system is provided that comprises a first container, a second container and a fluorescence detection device. The first container comprises a first set of chemicals and/or agents and is closed prior to use. The second container comprises a second set of chemicals and/or agents that are at least in part distinct from the chemicals and/or agents of the first set. The first container comprises a lid, that can be opened when the first container and the second container are combined to form a single, fluid tight assembly, in order to allow the contents of the first container to enter the second container.
Patent EP-4082290-A1 (EP)
Inventor: RYU JINSOOK
IPC: H04W76/00
Filed: 2021-03-01
Abstract: A session management function, SMF, receives a first message from a wireless device. The first message comprises a request for offloaded processing of data associated with the application. The SMF sends a second message to the wireless device. The second message indicates a rejection or an acceptance of the request for offloaded processing of data.
Patent EP-4135542-A1 (EP)
Inventor: HEDARCHET STEPHANE
IPC: H04W12/08
Filed: 2021-04-13
Abstract: The present invention concerns a method (100) for authenticating use of a cartridge with an aerosol generation device comprising a control unit configured to adjust its operation according to operational settings upon receiving a control command; the method (100) comprising the following steps: - associating (110) a cartridge unique identifier with a purchasing user identifier to form purchase information; - storing (120) the purchase information in a distant server; - comparing (140) the purchase information with a request for using, wherein the request for using comprises a cartridge unique identifier and a consuming user identifier; - based on said comparison, generating (145) a control command to control the operation of the aerosol generation device according to this control command.
Patent EP-4138795-A1 (EP)
Inventor: MUNRO HUGH SEMPLE
IPC: A61K31/7016
Filed: 2021-04-19
Abstract: L'invention concerne un ou plusieurs agents choisis parmi les acides carboxyliques organiques, les acides réducteurs non carboxyliques organiques, l'oxyde nitrique (NO), une composition génératrice d'oxyde nitrique, une combinaison ou une association combinable d'ingrédients pour une composition générant de l'oxyde nitrique, et des mélanges associés, pour une utilisation en tant qu'agent antiviral contre le coronavirus du SARS-CoV ou le coronavirus du SARS-CoV-2.
Patent EP-4149922-A1 (EP)
Inventor: KLUN THOMAS P
IPC: C08J7/18
Filed: 2021-04-22
Abstract: L'invention concerne un composé comprenant un groupe perfluoré lié à au moins un groupe photo-initiateur terminal avec un groupe de liaison organique comprenant au moins une fraction amide. Le composé comprend typiquement le produit de réaction (par exemple d'addition de Michael) de i) un composé comprenant un groupe acryle et un groupe photo-initiateur ; et ii) un composé perfluoré à fonction amino. L'invention concerne également une composition comprenant au moins un monomère, oligomère ou une combinaison de ceux-ci polymérisable par voie radicalaire libre (par exemple fluoré) ; et le composé photo-initiateur fluoré décrit et des procédés.
Patent EP-4285627-A1 (EP)
Inventor: RODRIGUEZ MEMBRIVE JAIME
IPC: H04W16/22
Filed: 2021-05-28
Abstract: L'invention concerne un dispositif informatique (110) qui génère, à partir d'un graphe de réseau représentant une pluralité d'éléments de réseau dans un réseau de communication sans fil (100) et sur la base d'une pluralité de mesures de performance du réseau, un modèle du réseau de communication sans fil (100) qui regroupe les éléments de réseau présentant des environnements radio similaires (170). Le dispositif informatique (110) génère également une recommandation de configuration de réseau (370) pour au moins l'un des éléments de réseau sur la base du modèle.
Patent EP-4154243-A1 (EP)
Inventor: LABBE MARK
IPC: G10D3/173
Filed: 2021-05-13
Abstract: A pick (100) for plucking a string of a stringed musical instrument including front (108) and rear sides (110), a fore end (102) having a curved tip (106), and an aft end (106). The pick further includes a plurality of raised formations (112) provided on at least one of the front (108) and rear sides (110) and arranged to produce multiple strikes of the string per pluck to achieve desired harmonic effects.
Patent EP-4171646-A1 (EP)
Title: Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition
Inventor: POSTEL RUBEN
IPC: A61K47/64
Filed: 2021-06-22
Abstract: The invention relates to a conjugate for transferring an effector molecule from outside a cell into said cell, the conjugate comprising at least one effector molecule to be transferred into the cell, at least one saponin of the mono-desmosidic triterpene glycoside type or the bi-desmosidic triterpene glycoside type, and at least one single-domain antibody (sdAb), covalently bound to each other, wherein the sdAb is capable of binding to a cell-surface molecule of said cell. The invention also relates to a pharmaceutical composition comprising the conjugate of the invention. Furthermore, the invention relates to a pharmaceutical composition of the invention, for use as a medicament. In addition, the invention relates to a pharmaceutical composition of the invention, for use in the treatment or the prophylaxis of any one or more of: a cancer, an auto-immune disease such as rheumatoid arthritis, an enzyme deficiency, a disease related to an enzyme deficiency, a gene defect, a disease relating to a gene defect, an infection such as a viral infection, hypercholesterolemia, primary hyperoxaluria, haemophilia A, haemophilia B, alpha-1 antitrypsin related liver disease, acute hepatic porphyria, an amyloidosis and transthyretin- mediated amyloidosis. The invention also relates to an in vitro or ex vivo method for transferring the conjugate from outside a cell to inside said cell or for transferring the effector molecule comprised by the conjugate of the invention from outside a cell to inside said cell, preferably to the cytosol of said cell.
Patent EP-4167987-A1 (EP)
Inventor: CLEMENT BERND
IPC: A61P1/16
Filed: 2021-06-17
Abstract: Eine Methode zur Prävention und Behandlung von Adipositas, nichtalkoholischen Fettlebererkrankungen, alkoholischen Fettlebererkrankungen, nichtalkoholischen Steatohepatitiden, Leberzirrhosen, Leberfibrosen, erhöhten Leberenzymwerten (ALT, AST, ALP), hepatozellulären Karzinomen, Hypercholesterinämien und damit verbunden Herz-Kreislauf-Erkrankungen, Insulinresistenzen, beeinträchtigten Glucose-Toleranzen, Hyperglykämien, Diabetes Mellitus Typ II, und dem metabolischen Syndrom. Diese Methode umfasst die Inhibition von mARC1 im Patienten durch chemische Verbindungen (Hemmstoffe, Inhibitoren) der allgemeinen Struktur: (I) Mit Hemmstoffen und Inhibitoren sind alle chemischen Verbindungen gemeint, die die Umsetzungsrate von mARC1 senken bzw. herunterregulieren. Herunterregulierung im Patienten meint, dass durch die Hemmstoffe in einem Arzneimittel eine niedrigere Umsetzungsrate im Patienten an durch mARC1 katalysierten Reaktionen erzielt wird. In gleicher Weise werden im Patienten durch ein Arzneimittel mit den beschriebenen Verbindungen Protein-Protein Interaktionen herunterreguliert, an denen mARC1 beteiligt ist. Mit Hemmstoffe sind zudem auch alle Substanzen gemeint, die den Abbau eines anderen Arzneimittels durch mARC1 hemmen, damit dieser in ausreichend hoher therapeutischer Konzentration vorliegt.
Patent EP-4165834-A1 (EP)
Title: Edge controller for a facility
Inventor: MAJEWSKI JOSEPH
IPC: G05B19/02
Filed: 2021-06-14
Abstract: An edge controller may be used for obtaining device data from one or more local devices at a local facility and to provide a representation of at least some of the device data to a remote server. The edge controller may include a network communication port, a cellular communication port and a device communication port. A controller is operatively coupled to the network communication port, the cellular communication port and the device communication port and is configured to receive configuration information and to install the received configuration information on the edge controller. The installed configuration information configures the controller to obtain the device data from the one or more local devices and to send a representation of at least some of the device data to the remote server.
Patent EP-4176027-A1 (EP)
Inventor: ERKEL HANS JÜRGEN
IPC: C10M161/00
Filed: 2021-07-01
Abstract: The invention relates to polyurea lubricating grease compositions containing polyurea thickeners and at least one organic carbonate, to lubrication points or components containing the polyurea lubricating grease composition, to a seal comprising sealing material from fluorinated elastomers and to the use of the lubricating greases.
Patent EP-4091317-A1 (EP)
Inventor: FEATHERSTONE WALTER
IPC: H04L12/46
Filed: 2021-01-08
Abstract: The present disclosure relates to a communication method and system for converging a 5 th -Generation (5G) communication system for supporting higher data rates beyond a 4 th -Generation (4G) system with a technology for Internet of Things (IoT). The present disclosure may be applied to intelligent services based on the 5G communication technology and the IoT-related technology, such as smart home, smart building, smart city, smart car, connected car, health care, digital education, smart retail, security and safety services. Disclosed is a method of providing a service in a Multi-access Edge Computing, MEC, network, comprising the steps of: providing a pod in an edge cloud node, wherein the pod comprises a software container for providing an application that offers a service to one or more subscribers; associating with the pod a status related to an active or registered subscriber, wherein an active subscriber is currently interacting with the pod and a registered subscriber is not currently interacting with the pod, but has interacted previously; wherein, provided that the pod has at least one registered subscriber, the pod is maintained in the edge cloud node.
Patent EP-4182650-A1 (EP)
Inventor: MARKOV STANISLAV NIKOLAEV
IPC: A61B5/01
Filed: 2021-07-16
Abstract: A non-contact temperature scanning system capable of high-speed determination of core body temperature T C  by estimating a representative skin temperature T S  of a subject from a thermal image. The system employs a biophysical model which considers heat transfer properties. In particular, the model takes into consideration of the ambient temperature T A  and relative humidity R h  in addition to estimating T S  from a thermal image. Once T S  is determined, T C  can be calculated based on the biophysical model which takes into consideration T A  and R h .
Patent EP-4233082-A1 (EP)
Inventor: SUN QINGJUN
IPC: H01F27/08
Filed: 2021-08-13
Abstract: A transformer including a core, a plurality of winding coils arranged in proximity of the core to inductively couple to the core, a plurality of air-gaps to allow air flow in the proximity of at least one of the core and winding coils, and an air-flow re-director including a plurality of independently adjustable surfaces angled to re-direct a flow of a portion of a cooling air received into the re-director into at least one pre-determined air-gap.
Patent EP-4196047-A1 (EP)
Inventor: GERHARDT LUTZ CHRISTIAN
IPC: A61C17/22
Filed: 2021-08-12
Abstract: The present invention is directed to a controller (100) for generating a control signal for an oral care system (200), wherein the controller (100) is configured for receiving orientation data generated by the oral care system (200), wherein the orientation data describes at least one angle (102) between the oral care system (200) and a target tissue surface (300) in an oral cavity (400) or the angle relative to a reference vector, for instance the gravity vector, wherein the controller (100) is configured for comparing the received orientation data with at least one pre-defined orientation condition, and wherein the controller (100) is configured for generating a first control signal to trigger or adapt an oral care procedure performed by the oral care system (200) if the received orientation data fulfills the pre-defined orientation condition.
Patent EP-4211646-A1 (EP)
Inventor: MARTINELLI EUGENIO
IPC: G06T7/00
Filed: 2021-08-20
Abstract: The present invention provides a computer-implemented method for analysing cell culture image data, in particular for analysing the spatiotemporal behaviour of the occurrence of a cellular event in a cell culture. The method comprise obtaining image data comprising a set of images of the cell culture at a plurality of consecutive time points, using an image analysis algorithm to determine the position of cells in at least a first population of cells in each of the images, linking at least some of the positions of cells in the images into respective cell tracks, and identifying the timing and position of occurrence of a cellular event in each of a plurality of cell tracks. The method may also comprise obtaining a spatiotemporal map of the events that have been identified, and quantifying the spatiotemporal pattern of occurrence of the event.
Patent EP-4116467-A1 (EP)
Inventor: XU GANG
IPC: C30B29/40
Filed: 2021-02-05
Abstract: The present disclosure discloses a reaction chamber, including a chamber body, the chamber body being connected to an upper cover by an insulation member, the chamber body and the upper cover forming an inner chamber, and the upper cover being provided with a through-hole that is communicated with the inner chamber; a gas inlet mechanism including an insulation body at least partially arranged in the through-hole, a gas inlet channel being arranged in the insulation body, a flange part being arranged on one side of the insulation body facing away from the inner chamber, the flange part being grounded and configured to communicate a gas inlet end of the gas inlet channel with a gas output end of a gas inlet pipe configure to transfer a reaction gas, a gas outlet end of the gas inlet channel being communicated with the inner chamber, the gas inlet channel including at least two channel segments, which are sequentially communicated in an axial direction of the through-hole, and orthographic projections of any two adjacent channel segments on a plane perpendicular to the axial direction of the through-hole being staggered from each other. The present solution solves the problem that accidental sparking is easy to occur in an existing reaction chamber.